The healthcare cybersecurity market size is estimated to grow from USD 20 billion in 2024 to reach USD 24 billion in 2025 and USD 115 billion by 2035, representing a higher CAGR of 17.0% during the forecast period. Currently, malware segment holds the highest share (over 25%) of healthcare cybersecurity market growth. Presently, the on-premises segment also holds the highest share (65%) of the healthcare cybersecurity market size. According to our market analysis, the hospitals segment is holdin...

Notably, companies, such as Amway (US), Bayer (Germany), and Abbott (US) are focusing on tech-driven personalized nutrition and supplements. For instance, in June 2025, Abbott (US) initiated a new research program (The Healthy Food Rx Program) to deliver personalized meal-based food boxes to the patients with diabetes, offering nutrition education to improve overall health outcomes. This research shows that participants experienced improvement in physical health and achieve greater satisfaction...

Owing to its significances and rising demand for targeted drug delivery devices, several industrial players are undertaking initiatives to develop nanomedicine for drug delivery. For instance, in February 2025, IIT Madras (Indian Institute of Technology, Madras, India) researcher’s team have developed a patented nanotechnology for breast cancer treatment. Owing to the successful outcomes, this researcher team is seeking partnerships with pharmaceutical industries for clinical trials and commer...

The significances offered by the AI in ultrasound has catered to the attention of industrial players for innovation. For instance, in January 2025, Samsung Medison (affiliate of Samsung Electronics, South Korea) launched an AI-powered ultrasound systems for advanced Ob-Gyn applications. Likewise, several market players, such as Medtronic (US), Philips (Netherland) and CloudMex (US) are aiming for designing AI-powered portable / handheld ultrasound scanners which can help in remote diagnosis. The...

The global viral vector manufacturing market, valued at USD 704 million in 2024, is estimated to reach USD 799 million in 2025 and USD 2,315 million by 2035, representing a CAGR of 11.23% during the forecast period. Over the past few years, these vectors have emerged as the key pre-requisites for cell and gene therapy manufacturing. It is worth mentioning that, till January 2023, over 25 viral vector based gene therapy products have been approved by different regulatory agencies, worldwide. In t...

Several market players have shown active interest in the field to initiate technological innovations. The primary focus of industrial players is on the development of computational tools, such as CRISPR gene editing for the modification of genetic material. For instance, in February 2025, researchers team at MIT’s McGovern Institute and the Broad Institute of MIT and Harvard found TIGR (Tandem Interspaced Guide RNA), an RNA guides system with diverse functionalities in gene editing. The consi...

The global digital twin market size is estimated to grow from $12.8 billion in 2024 to $240.3 billion in 2035, growing at a CAGR of 30.54% during the forecast period, till 2035. The growth of digital twin market is driven by a number of key factors. For instance, the growing adoption of IoT technology has enabled the development of intricate digital replicas of various industrial processes, assets and systems. This technology, coupled with artificial intelligence and machine learning, has enable...

Market players, such as Siemens Healthcare (Germany), GE Healthcare (US) and AliveCor (US) are undertaking strategic initiatives to strengthen their product portfolio. For instance, in January 2025, Philips (US) launched AI enabled CT 5300 at 23rd Asian Oceanian Congress of Radiology (ACOR) 2025. This revolutionary X-ray CT diagnosis system is equipped with advanced AI capabilities for diagnosis and screening diseases with higher accuracy. As more market players continue to innovate new AI techn...

Considering the increasing demand, market players are actively undertaking initiatives to encourage technological innovations in this field. For instance, in June 2025, Cosmo Pharmaceutical (Ireland) unveils its first-of-its-kind case study of its medical device software application which is connected with Medtronic GI Genius™ intelligent endoscopy module (an AI-powered platform for gastrointestinal endoscopy), with Apple Vision Pro. Similar to Cosmo Pharmaceutical (Ireland), various market pl...

The global plant based protein expression market, valued at USD 2.42 billion in 2025, is projected to reach USD 2.98 billion in 2026 and USD 5.81 billion by 2035, with a 7.68% CAGR during the forecast period 2026 to 2035. It is worth highlighting that our research indicates that the existing mammalian cell capacities are likely to fulfill only 50% of the inflated demand (due to COVID-19) for biologics. In this context, plant based expression systems have emerged as a promising alternative fo...

It is worth noting that several researchers are currently conducting clinical studies on biodegradable devices, smart ingestible pills, biosensors and smart technology that helps to proactive disease management with real-time data monitoring. In addition, the market players are focusing on biodegradable material innovations, leveraging 3D printing and nanotechnology to create a synergistic ecosystem where monitoring, diagnosing and treatment can be done continually. The ongoing clinical need and...

It is worth noting that high pressure homogenization machinery also plays a significant role in cell lysis, and extraction to extract components like enzymes and proteins, which are used to make therapeutic drugs. Additionally, homogenizers aid in the development of nanoparticles formulation that are widely used as drug delivery system to enhance drug absorbency in the body.Notably, the benefits offered by high-shear homogenizers, the pharmaceutical industry is increasingly utilizing this machin...

Several industrial players are increasing initiatives for innovations and expanding its application in healthcare. For instance, in June 2025, a latest Neoplas Argon Jet system, a cold plasma device developed through a German European scientific collaboration led by Leibniz Institute for Plasma Science and Technology and Neoplas Med (Germany) has been launched in Oman. This newly launched Neoplas Argon Jet system offers a non-invasive alternative treatment to treat infections. These innovations...

The biologics fill finish manufacturing market, valued at USD 4.4 billion in 2025, is projected to reach USD 4.7 billion in 2026 and USD 8.4 billion by 2035, representing a CAGR of 6.71%, during the forecast period 2026 to 2035. Through our new market research study, we have identified the key market trends, competitive landscape, market forecast and opportunity for biologics fill finish service providers. The biologics fill finish manufacturing market growth over the next decade is expected to...

The continuous adoption of disposable mixer for bioreactor feed preparation offers a competitive advantage to market players to meet future demands and requirement of technological innovations. It is worth mentioning that the current focus will be on advanced sensor integration for real-time process optimization. In addition, numerous industrial players are emphasizing integrating artificial intelligence with single-use mixer for quality control and process optimization.For instance, in March 2...

The global virtual health services market is expected to be valued at USD 86.40 billion in 2025 and is expected to reach USD 1,077.21 billion by 2035. It is important to highlight here that the key players of industries are forging several partnership agreements which is likely to propel technological innovations in this industry. For instance, in September 2024, Hackensack Meridian Health partnered with K Health to launch a new 24 / 7 virtual primary care service aiming to offer east access to...

several industrial players have shown active interest in the field for technological innovations and product launch. For instance, in February 2025, Dr. Ronnapee Chaichawarat (profession of International School of Engineering, Chulalongkorn University, Thailand) launched exoskeleton wheelchair, a robotic suit specifically designed to help people with disabilities sit, stand and walk. Owing to the ongoing innovations, and rising incidence of neurological conditions, we believe that wheelchair mou...

Notably, the patient portal software has a broad scope in healthcare industry to manage emergencies and chronic conditions by offering quick access to medical information and assist in handling cases. Owing to the increasing adoption by patients and healthcare organizations, several market players have taken strategic initiatives to develop advanced patient portal software with innovative features.

Several market players, and numerous research organizations are accelerating their research on avian influenza vaccine, which is expected to be a key driver for the avian influenza vaccine market.For instance, in April 2025, The University of Cambridge–based DioSynVax and Singapore's ACM Biolabs have signed a strategic deal to jointly develop a next-generation universal avian flu vaccine. In addition to strategic partnerships, regulatory authorities are initiating vaccination programs to mitig...

The exosomes development and exosomes manufacturing market, valued at USD 24.2 million in 2025, is projected to reach USD 28.6 million in 2026 and USD 127.4 million by 2035, with a 18.1% CAGR during the forecast period 2026 to 2035. Over time, various research studies have demonstrated the potential of isolated exosomes in disease diagnosis and drug delivery applications, owing to their ability to act as biomarkers for various diseases and transport important functional elements. Presently, seve...